There is significant relationship between Beijing genotype family strains and resistance to the first-line anti-tuberculosis drugs in the Iranian population

被引：7
|
作者：
Keikha, Masoud [1 ,2 ,3 ]
机构：
[1] Mashhad Univ Med Sci, Antimicrobial Resistance Res Ctr, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Fac Med, Dept Microbiol & Virol, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Student Res Comm, Mashhad, Razavi Khorasan, Iran
来源：
JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES | 2020年 / 19卷
关键词：
MYCOBACTERIUM-TUBERCULOSIS STRAINS; MULTIDRUG-RESISTANT; GENETIC DIVERSITY; ASSOCIATION; PREVALENCE; PATTERNS; MUTATIONS; LINEAGE; CHINA;
D O I：
10.1016/j.jctube.2020.100161
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Pulmonary tuberculosis: Resistance pattern to first line anti-tuberculosis drugs in the Coimbra District, 2000-2011
    Eufrasio, R.
    Alcobia, M.
    Correia, L.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2017, 23 (05) : 300 - 302
  • [32] Correlations among the plasma concentrations of first-line anti-tuberculosis drugs and the physiological parameters influencing concentrations
    Cheng, Lin
    Luo, Ming
    Guo, Yan
    Fan, Yunfan
    Wang, Pengsen
    Zhou, Gang
    Qin, Shiwei
    Weng, Bangbi
    Li, Peibo
    Liu, Zhirui
    Liu, Songtao
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [33] Spontaneous Adverse Event Reporting of First-Line Anti-Tuberculosis Drugs in One Regional Pharmacovigilance Center
    Park, H.
    Jung, G.
    Hwang, H.
    Shin, K.
    Kim, M.
    Lee, G.
    Kim, K.
    Lee, M.
    Park, S.
    DRUG SAFETY, 2011, 34 (10) : 929 - 929
  • [34] First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform
    Cao, Jun
    Mi, Yijun
    Shi, Cuilin
    Bian, Yicong
    Huang, Chenrong
    Ye, Zhijian
    Liu, Linsheng
    Miao, Liyan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (02) : 485 - 491
  • [35] CUTANEOUS ADVERSE DRUG REACTION AND SUBSEQUENT RE-CHALLENGE WITH FIRST-LINE ANTI-TUBERCULOSIS DRUGS
    Chua, Angeline
    Lim, Leo
    Chee, Cynthia
    Wang, Yee-Tang
    RESPIROLOGY, 2017, 22 : 214 - 214
  • [36] Incidence of adverse reactions caused by first-line anti-tuberculosis drugs and treatment outcome of pulmonary tuberculosis patients in Morocco
    Mariam El Hamdouni
    Samir Ahid
    Jamal Eddine Bourkadi
    Jouda Benamor
    Mohammed Hassar
    Yahia Cherrah
    Infection, 2020, 48 : 43 - 50
  • [37] Incidence of adverse reactions caused by first-line anti-tuberculosis drugs and treatment outcome of pulmonary tuberculosis patients in Morocco
    El Hamdouni, Mariam
    Ahid, Samir
    Bourkadi, Jamal Eddine
    Benamor, Jouda
    Hassar, Mohammed
    Cherrah, Yahia
    INFECTION, 2020, 48 (01) : 43 - 50
  • [38] Magnitude of Phenotypic and MTBDRplus Line Probe Assay First-Line Anti-Tuberculosis Drug Resistance Among Tuberculosis Patients; Northwest Ethiopia
    Yigzaw, Wubet Birhan
    Torrelles, Jordi B.
    Wang, Shu-Hua
    Tessenna, Belay
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 497 - 505
  • [39] Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre
    Shu, C-C.
    Lee, C-H.
    Lee, M-C.
    Wang, J-Y.
    Yu, C-J.
    Lee, L-N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (07) : 934 - 939
  • [40] Anti-Tuberculosis Drug Resistance in Strains of Mycobacterium Tuberculosis: Clinical Outcomes and Resistance Profile in a Multiethinic Population
    Figueiredo, R. G.
    Carvalho, L.
    Carvalho, J.
    Matos, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345